EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activity

Akitomo Yokokawa iD, Hayato Shimazaki, Shunji Igarashi, Yoshiki Tagawa, Naoki Hisada, Hiromi Shibasaki iD

British Journal of Clinical Pharmacology · 2026-08 · 92 (8) · 2899-2908

DOI: 10.1002/bcp.70589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 30.04.2026. Verfasst von Akitomo Yokokawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmacy and Experimental Therapeutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Melatonin, Cytochrome P-450 CYP1A2, Caffeine. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cytochrome P450 1A2 (CYP1A2) exhibits substantial interindividual variability, necessitating appropriate phenotyping strategies for personalized pharmacotherapy. This study evaluated endogenous melatonin partial metabolic clearance (CL m(MEL) ), calculated from urinary 6‐hydroxymelatonin (6‐O‐MEL) excretion and plasma melatonin (MEL) exposure, as a potential endogenous marker of CYP1A2 activity and compared it with caffeine (CA)‐based indexes.

Methods

Eighteen healthy adults received 142–146 mg of CA following 48 h of CA abstinence. Blood samples were collected at 4, 6, 24 and 26 h post‐dose, and urine was collected over two 2‐h intervals (4–6 and 24–26 h). CA clearance (CL CA ) was derived from the plasma CA AUC using noncompartmental analysis, and CL m(MEL) was calculated as urinary 6‐hydroxymelatonin excretion divided by the corresponding plasma melatonin AUC.

Results

Mean CL CA was 4.71 ± 2.97 L/h. CL m(MEL) values were comparable between sampling intervals (54.65 ± 15.87 vs . 53.66 ± 25.81 L/h) and showed significant correlations with CL CA ( r = 0.57 and 0.67) and plasma paraxanthine/CA (PX/CA) ratios ( r = 0.63 and 0.65).

Conclusions

Endogenous CL m(MEL) correlates with established caffeine‐derived CYP1A2 phenotyping indexes and may represent a probe‐free approach for CYP1A2 phenotyping. Further validation under CYP1A2 induced and inhibited conditions is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninCytochrome P-450 CYP1A2CaffeineHumansAdultMaleFemaleBiomarkersYoung AdultMetabolic Clearance Rate

Stichwörter der Autor:innen

6‐hydroxymelatoninCYP1A2LC–MS/MSendogenous phenotypingmelatonin

Substanzen

MelatoninCytochrome P-450 CYP1A2CaffeineCYP1A2 protein, humanBiomarkers6-hydroxymelatonin

Autor:innen und Institutionen

  • Laboratory of Clinical Pharmacy and Experimental Therapeutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

ORCID-Profile: Akitomo Yokokawa, Hiromi Shibasaki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yokokawa, A., Shimazaki, H., Igarashi, S., Tagawa, Y., Hisada, N., & Shibasaki, H. (2026). Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activity. British Journal of Clinical Pharmacology, 92(8), 2899-2908. https://doi.org/10.1002/bcp.70589

Vancouver

Yokokawa A, Shimazaki H, Igarashi S, Tagawa Y, Hisada N, Shibasaki H. Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activity. British Journal of Clinical Pharmacology. 2026;92(8):2899-2908. doi:10.1002/bcp.70589

BibTeX
@article{Yokokawa2026,
  author = {Yokokawa, Akitomo and Shimazaki, Hayato and Igarashi, Shunji and Tagawa, Yoshiki and Hisada, Naoki and Shibasaki, Hiromi},
  title = {Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activity},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  volume = {92},
  number = {8},
  pages = {2899--2908},
  doi = {10.1002/bcp.70589}
}
Kostenlos starten →